As the coronavirus spreads, drug pricing legislation remains stalled

New York Times

27 June 2020 - For both parties, taking action to reduce the cost of prescription drugs was a banner policy issue before the coronavirus outbreak. Does it still have a chance?

When President Trump visited Senate Republicans last month for the first time since the coronavirus pandemic began ripping across the country, Senator Charles E. Grassley, the powerful chairman of the Finance Committee, confronted him about whether he still wanted to fulfil his years-old promise of lowering the cost of prescription drugs.

Read New York Times article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Regulation , Pricing